Global Renal Denervation Market valued at $140 Million in 2022, is growing at a lucrative growth rate of 40%
Resistant hypertension is a blood pressure that remains elevated above target levels despite use of anti-hypertensive medications. About 12-15% of the population treated for high blood pressure suffers from resistant hypertension. Renal denervation is a minimally invasive procedure used to treat resistant hypertension. As the geriatric population is rising, the number of people suffering from hypertension and the resistant hypertension is also growing which is driving the RDN market growth. Rising Prevalence of Hypertension is driving the Renal Denervation Market Growth According to WHO, currently more than one billion people across the world are suffering from hypertension which is expected to grow to 1.6 billion by 2025. WHO estimated that less than one in five people have their hypertension under control, either due to non-adherence or resistance to medication. This is leading to growing prevalence of hypertension/resistant hypertension, thereby driving the growth of the renal d...